close
MENU
Hot Topic Hawke’s Bay
How to guide
How to guide
Home
The NBR List
NBR View
NBR Marketplace

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Hot Topic Hawke’s Bay
General Business
5 mins to read

Kiwi startup may be on frontier of enabling post-vaccine travel

Orbis Diagnostic tech could see pre-flight Covid immunity tests consisting of a finger prick.

Julie Iles Thu, 28 Jan 2021

A New Zealand startup could see its tech integrated on a massive scale to bring international travel back in a post-vaccine environment. 

Science startup Orbis Diagnostics, in partnership with multinational Idemia – the company behind biometric eGates – have announced an extension to their

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Julie Iles Thu, 28 Jan 2021
Contact the Writer: julie@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
Orbis international travel Covid-19 coronavirus vaccine research
Related News
Politics
5

MedSafe approval of Pfizer vaccine could be as soon as next week
Investment
1

Scientific startup raising $5.3m after pivoting to Covid-19 test
Related News
Politics
5

MedSafe approval of Pfizer vaccine could be as soon as next week
Investment
1

Scientific startup raising $5.3m after pivoting to Covid-19 test
Kiwi startup may be on frontier of enabling post-vaccine travel
General Business,
86161
true
Subscribe Login